0000899243-21-035503.txt : 20210909 0000899243-21-035503.hdr.sgml : 20210909 20210909211631 ACCESSION NUMBER: 0000899243-21-035503 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210903 FILED AS OF DATE: 20210909 DATE AS OF CHANGE: 20210909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louks Ronald Allen CENTRAL INDEX KEY: 0001706849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37792 FILM NUMBER: 211245667 MAIL ADDRESS: STREET 1: C/O NANTHEALTH, INC. STREET 2: 9920 JEFFERSON BLVD. CITY: CULVER CITY STATE: CA ZIP: 90232 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantHealth, Inc. CENTRAL INDEX KEY: 0001566469 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 273019889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 BUSINESS PHONE: (310) 853-7513 MAIL ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 FORMER COMPANY: FORMER CONFORMED NAME: Nant Health, LLC DATE OF NAME CHANGE: 20130108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-03 0 0001566469 NantHealth, Inc. NH 0001706849 Louks Ronald Allen C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 1 0 0 Chief Operating Officer Common Stock 2021-09-03 4 M 0 1505 0.5501 A 227362 D Common Stock 2021-09-03 4 S 0 1505 2.3354 D 225857 D Common Stock 2021-09-07 4 M 0 16613 0.5501 A 242470 D Common Stock 2021-09-07 4 S 0 16613 2.2963 D 225857 D Common Stock 2021-09-08 4 M 0 4700 0.5501 A 230557 D Common Stock 2021-09-08 4 S 0 4700 2.2516 D 225857 D Stock Option (right to buy) 0.5501 2021-09-03 4 M 0 1505 0.00 D 2029-08-12 Common Stock 1505 548495 D Stock Option (right to buy) 0.5501 2021-09-07 4 M 0 16613 0.00 D 2029-08-12 Common Stock 16613 531882 D Stock Option (right to buy) 0.5501 2021-09-08 4 M 0 4700 0.00 D 2029-08-12 Common Stock 4700 527182 D Represents the weighted average share price of an aggregate total of 1,505 shares sold in the price range of $2.31 to $2.38 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 16,613 shares sold in the price range of $2.25 to $2.32 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 4,700 shares sold in the price range of $2.25 to $2.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date. /s/ Brandon Villery, as Attorney-in-Fact 2021-09-09